methylprednisolone has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcari, A; Centurioni, R; Evangelista, A; Freilone, R; Ladetto, M; Liberati, AM; Luminari, S; Massidda, S; Merli, F; Musuraca, G; Nassi, L; Patti, C; Pavone, V; Peli, A; Pulsoni, A; Re, A; Salvi, F; Spina, M; Stelitano, C; Tani, M; Tucci, A; Volpetti, S; Zanni, M | 1 |
| Kanda, H; Kawahata, K; Ohshima, M; Yamamoto, K | 1 |
1 trial(s) available for methylprednisolone and Cardiotoxicity
| Article | Year |
|---|---|
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Carmustine; Combined Modality Therapy; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prognosis; Recurrence; Remission Induction; Survival Analysis; Teniposide; Treatment Outcome | 2019 |
1 other study(ies) available for methylprednisolone and Cardiotoxicity
| Article | Year |
|---|---|
Sinus bradycardia after intravenous pulse methylprednisolone therapy in patients with systemic lupus erythematosus.
Topics: Adult; Bradycardia; Cardiotoxicity; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Sick Sinus Syndrome | 2019 |